Ignite Creation Date:
2024-05-06 @ 5:02 PM
Last Modification Date:
2024-10-26 @ 2:21 PM
Study NCT ID:
NCT05176080
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-05-06
First Post:
2021-11-18
Brief Title:
Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive HER2-negative Advanced Breast Cancer
Sponsor:
Henan Cancer Hospital
Organization:
Henan Cancer Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-08
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-01-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-11-18
First Submit QC Date:
December 15 2021
Study First Post Date:
2022-01-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-03
Last Update Post Date:
2023-05-06
Last Update Post Date Type:
ACTUAL